Table: Modalis Therapeutics - 9-MTH group results

Modalis Therapeutics

05/11/2021 06:00

Nov 5 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2021        Sep 30, 2020     Dec 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             1 mln              340 mln                    
                 (-99.7 pct)                                      
  Operating     loss 677 mln        loss 168 mln                  
  Recurring     loss 661 mln        loss 209 mln                  
  Net           loss 181 mln        loss 214 mln                  
  EPS           loss 6.32 yen       loss 8.34 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T